8AWW
Transthyretin conjugated with a tafamidis derivative
Summary for 8AWW
Entry DOI | 10.2210/pdb8aww/pdb |
Related | 3tct |
Descriptor | Transthyretin, ~{N}-(6-azanylhexyl)-2-[3,5-bis(chloranyl)phenyl]-1,3-benzoxazole-6-carboxamide (3 entities in total) |
Functional Keywords | ttr, tafamidis, protein-drug conjugates, drug design, cancer therapy., transport protein |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 2 |
Total formula weight | 26219.05 |
Authors | Cerofolini, L.,Vasa, K.,Bianconi, E.,Salobehaj, M.,Cappelli, G.,Licciardi, G.,Perez-Rafols, A.,Padilla Cortes, L.D.,Antonacci, S.,Rizzo, D.,Ravera, E.,Calderone, V.,Parigi, G.,Luchinat, C.,Macchiarulo, A.,Menichetti, S.,Fragai, M. (deposition date: 2022-08-30, release date: 2023-07-12, Last modification date: 2024-02-07) |
Primary citation | Cerofolini, L.,Vasa, K.,Bianconi, E.,Salobehaj, M.,Cappelli, G.,Bonciani, A.,Licciardi, G.,Perez-Rafols, A.,Padilla-Cortes, L.,Antonacci, S.,Rizzo, D.,Ravera, E.,Viglianisi, C.,Calderone, V.,Parigi, G.,Luchinat, C.,Macchiarulo, A.,Menichetti, S.,Fragai, M. Combining Solid-State NMR with Structural and Biophysical Techniques to Design Challenging Protein-Drug Conjugates. Angew.Chem.Int.Ed.Engl., 62:e202303202-e202303202, 2023 Cited by PubMed: 37276329DOI: 10.1002/anie.202303202 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.6 Å) |
Structure validation
Download full validation report